Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.09)
# 526
Out of 5,090 analysts
387
Total ratings
43.96%
Success rate
15.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $35.64 | +40.29% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.31 | +125.99% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $464.56 | +22.70% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.63 | +611.11% | 17 | Aug 4, 2025 | |
| ATAI Atai Beckley | Maintains: Buy | $10 → $15 | $4.39 | +241.69% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $13.38 | -25.26% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $2.21 | +126.13% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.54 | +1,767.41% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.96 | +978.36% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $40.24 | +148.51% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.09 | +203.16% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.98 | +409.81% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $5.04 | +1,091.66% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $64.67 | +23.70% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.16 | +163.85% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.34 | +591.24% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $38.25 | +83.01% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $29.01 | +175.77% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.63 | +280.23% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.38 | +196.30% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $12.48 | +340.88% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $6.87 | +1,502.33% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $72.73 | +16.87% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $5.95 | +2,421.01% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $13.07 | +420.47% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $155.27 | +118.97% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $35.64
Upside: +40.29%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $5.31
Upside: +125.99%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $464.56
Upside: +22.70%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.63
Upside: +611.11%
Atai Beckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.39
Upside: +241.69%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $13.38
Upside: -25.26%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $2.21
Upside: +126.13%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.54
Upside: +1,767.41%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.96
Upside: +978.36%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $40.24
Upside: +148.51%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $23.09
Upside: +203.16%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.98
Upside: +409.81%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $5.04
Upside: +1,091.66%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $64.67
Upside: +23.70%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.16
Upside: +163.85%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.34
Upside: +591.24%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $38.25
Upside: +83.01%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $29.01
Upside: +175.77%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.63
Upside: +280.23%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.38
Upside: +196.30%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $12.48
Upside: +340.88%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $6.87
Upside: +1,502.33%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $72.73
Upside: +16.87%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $5.95
Upside: +2,421.01%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $13.07
Upside: +420.47%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $155.27
Upside: +118.97%